Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
International Atomic Energy Agency
Eligibility
Inclusion criteria
Inclusion criteria: WRA with HIV infection Known HIV positive status and stable on ART who are: Non pregnant (negative on urine pregnancy test), non-lactating WRA, Hb more than 11g/dL, Corrected serum ferritin more than 50mcg/L, CRP more than 5mg/L
Exclusion criteria
Exclusion criteria: Healthy control WRA History of -Major illnesses or blood transfusion in the last three months prior to study -Current anticoagulation use, for any indication -Menorrhagia for preceding 3 months -Other chronic inflammatory states/ diseases - Diabetes Mellitus, Rheumatoid arthritis, chronic obstructive pulmonary disease, severe obesity, Inflammatory bowel disease, ischemic heart disease, malignancy and Chronic liver disease. WRA with HIV infection -Same as those for healthy control WRA and -Opportunistic infections (OI) requiring hospitalisation or treatment of more than a week in the last three months prior to study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative estimate of the difference in long term iron balance due to effect of HIV induced chronic inflammation in WRA with HIV infection as compared to healthy controls.Timepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Labelled cohort that allows for subsequent testing of iron supplement interventions or absorption enhancersTimepoint: 18 months | — |
Countries
India
Contacts
Public ContactSavitha Anne Sebastian
St Johns Medical College, Bengaluru
Outcome results
None listed